Ono Pharmaceutical Retained Earnings (Accumulated Deficit) 2010-2024 | OPHLF
Ono Pharmaceutical retained earnings (accumulated deficit) for the quarter ending December 31, 2024 were $4.964B, a 0.25% decline year-over-year.
- Ono Pharmaceutical retained earnings (accumulated deficit) for 2024 were $5.3B, a 0.9% increase from 2023.
- Ono Pharmaceutical retained earnings (accumulated deficit) for 2023 were $5.253B, a 8.45% decline from 2022.
- Ono Pharmaceutical retained earnings (accumulated deficit) for 2022 were $5.738B, a 4.64% increase from 2021.